ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Survey Expected To Stimulate Surge Of Interest In Finding Etiological Factors In U .S. County-By-County Variations

April 19, 1974

FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011

April 16, 2010

John Mendelson Says M.D. Anderson Plans to Accelerate Role In Translational Research

May 7, 1999

Avon to Support Community Programs

January 7, 1994

Includes 8-page Business & Regulatory Report.

April 11, 2003

Kennedy Bill Would Extend Cancer Program Three Years, Kill Budget Bypass

May 4, 1979